ONM-400 nanoparticles encapsulated with payload interleukin-2 (OncoNano Medicine)

N/A

Report date: 2025/01/26 16:39:11

Base Information

Drug NameONM-400 nanoparticles encapsulated with payload interleukin-2 (OncoNano Medicine)
Drug Alias NameONM-400 IL-2 complex
ClassificationBiologics
Mechanisms of ActionInterleukin-2 receptor agonists
TargetsInterleukin-2 receptor
Therapy Area/IndicationsColorectal NeoplasmsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesOnconano Medicine Inc
China Registration ClassN/A

Develop Information

Active CompaniesOnconano Medicine Inc
Inactive CompaniesN/A
Active IndicationsColorectal Neoplasms
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A